Precise Cas9 targeting enables genomic mutation prevention.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29555762.
- Also identified by DOI 10.1073/pnas.1718148115 and PMC identifier 5889643.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Here, we present a generalized method of guide RNA "tuning" that enables Cas9 to discriminate between two target sites that differ by a single-nucleotide polymorphism. We employ our methodology to generate an in vivo mutation prevention system in which Cas9 actively restricts the occurrence of undesired gain-of-function mutations within a population of engineered organisms. We further demonstrate that the system is scalable to a multitude of targets and that the general tuning and prevention concepts are portable across engineered Cas9 variants and Cas9 orthologs. Finally, we show that the mutation prevention system maintains robust activity even when placed within the complex environment of the mouse gastrointestinal tract.
Medical subject headings
- CRISPR-Cas Systems
- Drug Resistance, Bacterial
- Escherichia coli
- Genomics
- Mutation